Updated CMS Guidelines for COVID-19 Tests and Booster Shot
Medisys Compliance
APRIL 20, 2022
On 4 th April 2022, CMS announced that more than 59 million Americans with Medicare Part B, including those enrolled in a Medicare Advantage plan, now have access to Food and Drug Administration (FDA) approved, authorized, or cleared over-the-counter COVID-19 tests at no cost.
Let's personalize your content